Brian Harvey

Royal College of Surgeons in IrelandIreland

Brian Harvey, Professor of Molecular Medicine, Royal College of Surgeons in Ireland Brian Harvey holds primary degrees in mathematics, physics and a PhD in biophysics from the National University of Ireland. He is Professor of Molecular Medicine at the Royal College of Surgeons in Ireland (www.rcsi.ie/molmed) and research professor at the Université de Paris Descartes and an Investigador at the Centro di Estudios Cientificos CECs Valdivia Chile. He was Ireland’s first and longest serving university vice-president for research from 1998-2010. His academic roles include Head of Department of Molecular Medicine at RCSI, Director of Research of the DOCTRID Research Institute (www.doctrid.ie), coordinator of the EU Marie Curie COFUND in assistive technologies (www.assistid.eu), scientific head of the EU COST Action ADMIRE (www.admirecost.eu) and coordinator of the National Biophotonics & Imaging Platform Ireland (www.nbipireland.ie). His role in promoting Irish biomedical research has been recognized by honours at home and abroad. He was awarded a knighthood (Chevalier) of the French Order of Merit in 2006 by the President of France and awarded the Order of Palmes Academiques by the Prime Minister of France in 2016, and was the recipient of the International Laureat Prix Servier in 2008. In 2000, Brian was elected member of the European Academy of Sciences and in 2007 elected to the Royal Irish Academy. In 2013, he was awarded a Doctor of Science honoris causa from Michigan State University. Brian has served on the European Research Council Advanced Awards Panel 2008-2016 and as president of the French National Research Agency ANR scientific evaluation council 2015-2016. His research specialty is in molecular endocrinology of steroid hormone actions in inflammation and cancer – see https://orcid.org/0000-0002-7388-8034 for publications

1books edited

2chapters authored

Latest work with IntechOpen by Brian Harvey

This book is an open access dissemination of the EU COST Action ADMIRE in Aldosterone/Mineralocorticoid Receptor (MR) physiology and pathophysiology. Aldosterone is the major hormone regulating blood pressure. Alterations in blood levels of aldosterone and genetic mutations in the MR receptor are major causes of hypertension and comorbidities. Many of the drugs in clinical use, and in development for treating hypertension, target aldosterone and MR actions in the kidney and cardiovascular system. The ADMIRE book assembles review chapters from 16 European ADMIRE laboratories providing the latest insights into mechanisms of aldosterone synthesis/secretion, aldosterone/MR physiology and signaling, and the pathophysiological roles of aldosterone/MR activation.

Go to the book